Ronald Caplan, founder and president of PMC Property Group, Inc., and his wife Ellen have donated $10 million to the NCI-designated Wistar Cancer Center in Philadelphia, now renamed the Ellen and Ronald Caplan Cancer Center of The Wistar Institute.
Research by Wistar Institute scientists shows how targeting a cleft in the retinoblastoma protein can kill tumor-protecting macrophages in ovarian cancer. The discovery provides a novel therapeutic target that could potentially make ovarian and other cancers more sensitive to immunotherapies.
